Ctrl K
PRJ-2601↩ from OFF-2026-0001
Novartis CSV remediation
Novartis Pharma AG·Life Sciences·TK·PM: Martina RossiPlanning
Current budgetversion 2 · current
Total budget
EUR 252,000
Contingency
EUR 12,000
Non-billable quota
8%
Work packages
| Code | Label | Amount |
|---|---|---|
| WP1 | Validation planning | EUR 90,000 |
| WP2 | Execution & testing | EUR 132,000 |
| WP3 | Reporting | EUR 30,000 |
Revision requests
BRQ-2601R2 · Project AddendumApproved
Requested by Manuel De Felice · effective 2026-08-01 — “Client added a second site; +40k execution.”
Proposed total: EUR 252,000 → EUR 292,000
Decision: “Second site confirmed.”
mints the next version
BRQ-2601R3 · Issue RevisionSubmitted
Requested by Manuel De Felice — “Re-rate senior consultant.”
Proposed total: EUR 252,000 → EUR 258,500
BRQ-2601R1 · Project AddendumApplied
Requested by Manuel De Felice · effective 2026-05-10 — “Scope increase on testing”
Proposed total: EUR 240,000 → EUR 252,000
Decision: “Justified by client scope change.”
Version history
v2 · 2026-05-10 · Edoardo Budini — Scope increase on testing
Total budget: 240,000 → 252,000Work package WP2: 120,000 → 132,000
v1 · 2026-04-01 · Manuel De Felice — Initial budget